Sandoval Elisabeth 4
4 · VYNE Therapeutics Inc. · Filed Dec 13, 2024
Insider Transaction Report
Form 4
Sandoval Elisabeth
Director
Transactions
- Award
Stock Option (right to buy)
2024-12-12+20,000→ 20,000 totalExercise: $2.40Exp: 2034-12-11→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]Represents the annual award to non-employee directors of the Issuer, awarded on the date of the Issuer's annual meeting of stockholders. The shares subject to the option vest on December 12, 2025, subject to the Reporting Person's continuous service through such date.